Indian Drug Firms
-
Maiden Pharmaceuticals responsible for the deaths of 66 children, says Gambia Parliamentary panel
The select committee recommended that the Indian medicine manufacturer should be blacklisted and its products be banned in West African nation.
Scroll Staff
-
Maiden Pharma seeks to reopen factory after drug regulator says no contaminants in cough syrups
On Tuesday, the DCGI said that the WHO drew a premature link between the deaths of 66 children in The Gambia and the cough syrups made by Haryana-based company.
Scroll Staff
-
WHO drew premature link between deaths of children in Gambia and India-made cough syrups, says DCGI
Test reports have shown that the syrups were not contaminated with diethylene glycol or ethylene glycol, the drug regulator said.
Scroll Staff
Trending
-
We will leave India if told to break encryption: WhatsApp tells Delhi HC
-
By mixing Carnatic and Hindustani, Mysore’s kings helped create a unique body of music
-
Why is BJP wooing Bengali-origin Muslims in Assam?
-
Ramachandra Guha: Why 2024 is India’s most important election since 1977
-
‘My son lost his job during demonetisation but at least it removed black money’
-
Haryana stops production of cough syrups linked to deaths of 66 children in The Gambia
State health minister said that 12 flaws were found during an inspection of the medicines and their manufacturing process.
Scroll Staff
-
Gambia Police begin probe into deaths of children linked to India-made cough syrups
President Adama Barrow’s office said that the foreign ministry had been asked to communicate the government’s ‘most profound concern’ to the Indian embassy.
Scroll Staff
-
Firm linked to Gambia deaths failed to meet standards for other drugs four times in India this year
Meanwhile, the Food and Drug Administration in Haryana said it was preparing to test samples of the four syrups, which were made for export.
Tabassum Barnagarwala
Video
-
Watch: K-Pop singer Aoora sings in Assamese as he collaborates with Nilotpal Bora in a new folk song
-
Watch Anu Malik and Sonu Nigam’s impromptu performance of ‘Main Hoon Na’ at Farah Khan’s home
-
Watch: Doordarshan newsreader faints on live TV in Kolkata owing to severe heat
-
Watch: Spice Girls sing ‘Stop’ as bandmates reunite to celebrate Victoria Beckham’s 50th birthday
-
Watch: Over 350 ballerinas come together to break the world record for standing on tip toes
-
Thalassemia patients complain of shortage of life-saving drug that removes excess iron from blood
However, Novartis, the sole manufacturer of the medicine, says that the stock is sufficient.
Priyanka Vora
-
Is 74% foreign direct investment in brownfield pharma really bad for Indian generics?
The new policy can keep Indian companies competitive and bring investment into the country.
Prashant Reddy